Lv5
1100 积分 2023-04-21 加入
Efficacy and safety of sovleplenib (HMPL-523) in adult patients with chronic primary immune thrombocytopenia in China (ESLIM-01): a randomised, double-blind, placebo-controlled, phase 3 study
1天前
待确认
Sovleplenib (HMPL-523), a novel Syk inhibitor, for patients with primary immune thrombocytopenia in China: a randomised, double-blind, placebo-controlled, phase 1b/2 study
1天前
待确认
Phase 1 and pharmacologic study of MS-275, a histone deacetylase inhibitor, in adults with refractory and relapsed acute leukemias
6个月前
已完结
Phase I and Pharmacokinetic Study of MS-275, a Histone Deacetylase Inhibitor, in Patients With Advanced and Refractory Solid Tumors or Lymphoma
6个月前
已完结
Examining the bleeding incidences associated with targeted therapies used in metastatic renal cell carcinoma
6个月前
已完结
Effect of Baduanjin on Blood Pressure Among Individuals With High-Normal Blood Pressure
6个月前
已完结
Entinostat suppresses hepatocellular carcinoma metastasis by upregulating AZGP1 through histone acetylation
7个月前
已完结
[The role of recombinant human thrombopoietin in critically ill patients with sepsis-associated thrombocytopenia: a clinical study]
8个月前
已完结
Recombinant human thrombopoietin improves platelet counts and reduces platelet transfusion possibility among patients with severe sepsis and thrombocytopenia: a prospective study
8个月前
已完结
Prognosis and rescue therapy for sepsis-related severe thrombocytopenia in critically ill patients
8个月前
已完结
皖公网安备34019202002308
